estradiol/etonogestrel intravaginal ring (MK-8342B) / Merck (MSD) - LARVOL DELTA

A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012) (clinicaltrials.gov) - P2 | N=666 | Completed | Sponsor: Organon and Co | Phase classification: P2b ➔ P2

Phase classification

Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062) (clinicaltrials.gov) - P3; N=2016; Terminated; Sponsor: Merck Sharp & Dohme Corp.; Active, not recruiting ➔ Terminated

Trial termination • Biosimilar

Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Treatment of Women With Primary Dysmenorrhea (MK-8342B-060) (clinicaltrials.gov) - P3; N=330; Recruiting; Sponsor: Merck Sharp & Dohme Corp.; Not yet recruiting ➔ Recruiting

Enrollment open • Biosimilar • Pain